Elevance HealthMEX:ELV 75 PS Ratio is 0.43 as of Jul. 11, 2026, which is 37% below its 10-year median of 0.68. GuruFocus rates MEX:ELV with a GF Score™ of 75/100 and a GF Value™ of MXN8,845.39 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 18 Healthcare Plans companies, Elevance Health ranks better than 61.11% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Elevance Health's share price is MXN7144.06.
Elevance Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was MXN16,457.06. Hence, Elevance Health's PS Ratio for today is 0.43.
Warning Sign:
Elevance Health Inc stock PS Ratio (=0.47) is close to 1-year high of 0.47.
The historical rank and industry rank for Elevance Health's PS Ratio or its related term are showing as below:
MEX:ELV'
s PS Ratio Range Over the Past 10 Years
Min: 0.32 Med: 0.68 Max: 0.89
Current: 0.47
During the past 13 years, Elevance Health's highest PS Ratio was 0.89. The lowest was 0.32. And the median was 0.68.
MEX:ELV's PS Ratio is ranked better than 61.11% of 18
companies
in the Healthcare Plans industry
Industry Median: 0.855
vs MEX:ELV: 0.47
Elevance Health Inc has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Elevance Health was 13.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 11.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 12.40% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 12.40% per year.
During the past 13 years, Elevance Health's highest 3-Year average Revenue per Share Growth Rate was 18.30% per year. The lowest was -11.10% per year. And the median was 11.80% per year.
Back to Basics: PS Ratio
Elevance Health (MEX:ELV) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Elevance Health PS Ratio Related Terms
Elevance Health PS Ratio Historical Data
* Premium members only.
The historical data trend for Elevance Health's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, Elevance Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elevance Health PS Ratio vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Elevance Health's PS Ratio distribution charts can be found below:
* The bar in red indicates where Elevance Health's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Elevance Health's Share Price of today is MXN7144.06. Elevance Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN16,457.06.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Elevance Health (MEX:ELV) has a PS Ratio of 0.43 as of Jul. 11, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Elevance Health and its competitors. This is 37% below median its historical median of 0.68. Over the past decade, Elevance Health's PS Ratio has ranged from 0.32 to 0.89. According to the industry distribution chart, Elevance Health ranks #7 out of 18 companies in the Healthcare Plans industry, placing it in the top 38.9%.
Is Elevance Health's PS Ratio too high?
Elevance Health's current PS Ratio of 0.43 is 37% below median its 10-year median of 0.68. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 0.89. The Healthcare Plans industry median PS Ratio is 0.86. Elevance Health's value of 0.43 is 49.7% below this industry median. Based on the distribution chart, Elevance Health ranks #7 out of 18 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Elevance Health has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's PS Ratio compare to CI and HUM?
According to the Healthcare Plans industry distribution chart, Elevance Health ranks #7 out of 18 companies for PS Ratio. This puts Elevance Health in the upper half of its industry. The industry median PS Ratio is 0.86. Elevance Health's value of 0.43 is 49.7% below this benchmark. Historically, Elevance Health's own PS Ratio has ranged from 0.32 to 0.89 over the past decade. While the company's 10-year median is 0.68 vs. the industry median of 0.86, Elevance Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Plans company?
The median PS Ratio among Healthcare Plans companies is 0.86, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elevance Health's current PS Ratio of 0.43 is 49.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Elevance Health and its competitors. For the Healthcare Plans industry, the median PS Ratio is 0.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elevance Health's current PS Ratio is 0.43, which is 37% below median its own 10-year median of 0.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (MEX:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN8,845.39, compared to a current price of MXN7,144.06 — trading 19.2% below its estimated fair value. The current PS Ratio is 0.43, which is 37% below median its 10-year median of 0.68 and 49.7% below the Healthcare Plans industry median of 0.86. Elevance Health's overall GF Score™ is 75/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Elevance Health (MEX:ELV), the current PS Ratio is 0.43 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elevance Health (MEX:ELV) Overvalued in 2026?
Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued.
The current stock price of MXN7,144.06 is trading 19.2% below its estimated GF Value™ of MXN8,845.39.
GuruFocus considers Elevance Health to be Modestly Undervalued.
Key valuation signals for MEX:ELV:
PS Ratio: 0.43 (37% below median its 10-year median of 0.68)
GF Value™: MXN8,845.39 vs. price of MXN7,144.06 (19.2% below fair value)
Industry Position: 49.7% below the Healthcare Plans median (#7 of 18)
No single metric tells the full story. See the MEX:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
75GF Score
Get the complete analysis for MEX:ELV
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ELV has been successfully added to your 
